Nitrosamine analysis in APIs and Medicines

ZÁZNAM | Proběhlo Čt, 23.4.2020

Projdeme aktuálně dostupné metody, regulační požadavky nebo vhodné analytické techniky jako GC/MS/MS nebo LC/MS/MS určené k provedení těchto analýz v prostředí cGMP. Prodiskutujeme také možnosti systémů Q-TOF.

Přejít na webinář

Agilent Technologies: Nitrosamine analysis in APIs and Medicines

In this seminar, we will discuss the regulatory requirements, the methods currently available, and the appropriate analytical techniques—such as GC/MS/MS or LC/MS/MS—to perform this analysis in a cGMP environment. We will also consider how other technologies, such as Q-TOF, can help prevent similar situations.

Presenter: Antonio Chana - Product Specialist Liquid Phase Separation, Agilent Technologies

Presenter: Marcus Chadha - LC-MS Field Application Specialist, Agilent Technologies

Presenter: Soma Dasgupta - PhD Application Engineer, GC/GCMS, Agilent Technologies

Agilent Technologies

Nitrosamine analysis in APIs and Medicines

Mohlo by Vás zajímat

Analysis of Aroma Components in Apples Using the Smart Aroma Database

Analysis of Acetaldehyde and Limonene in Recycled PET Using an HS-GCMS System (Carrier Gas: H2)

What Causes GC Capillary Column Performance Degradation, and How Can I Prevent It?

Aromatic Component Analysis of Gasoline According to ASTM D5580 Using the Brevis GC- 2050 Gas Chromatograph

Micro GC Analysis of Permanent Gas Impurities in PEM Fuel Cell-Grade Hydrogen